ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
This Quarter Return
+10.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$418M
AUM Growth
+$418M
(+4.4%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-5.1%
Top 10 Holdings %
Top 10 Hldgs %
32.81%
Holding
108
New
12
Increased
10
Reduced
35
Closed
7
Top Buys
| 1 |
HSP
HOSPIRA INC
HSP
|
$5.51M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$5.4M |
| 3 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$4.71M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.48M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$4.33M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$5.12M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$4.39M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$4.03M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$3.82M |
| 5 |
QGENF
QIAGEN NV
QGENF
|
$3.53M |
Sector Composition
| 1 | Healthcare | 87.28% |
| 2 | Financials | 0.93% |
| 3 | Industrials | 0.35% |
| 4 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $20.8M | 4.98% |
186,170
-20,550
| -10% | -$2.3M |
|
2
Biogen
BIIB
$19.4B
| $18.1M | 4.32% |
53,250
-1,770
| -3% | -$601K |
|
3
Gilead Sciences
GILD
$140B
| $17M | 4.06% |
180,390
-16,000
| -8% | -$1.51M |
|
4
Amgen
AMGN
$155B
| $15.1M | 3.62% |
95,000
-5,000
| -5% | -$796K |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $13.3M | 3.17% |
51,590
-520
| -1% | -$134K |
|
6
UnitedHealth
UNH
$281B
| $11.6M | 2.78% |
115,000
-13,000
| -10% | -$1.31M |
|
7
Viatris
VTRS
$12.3B
| $11.3M | 2.69% |
200,000
-30,000
| -13% | -$1.69M |
|
|
CTRX
8
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $10.7M | 2.57% |
206,820
+70,080
| +51% | +$3.64M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10.5M | 2.52% |
57,000
-3,000
| -5% | -$555K |
|
10
Medtronic
MDT
$119B
| $8.77M | 2.1% |
121,500
-28,500
| -19% | -$2.06M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $8.67M | 2.07% |
73,000
| – | – |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.62M | 2.06% |
21,000
+3,000
| +17% | +$1.23M |
|
13
McKesson
MCK
$85.4B
| $8.51M | 2.03% |
41,000
| – | – |
|
|
CYTO
14
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $8.46M | 2.02% |
2,169,625
| – | – |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $7.92M | 1.89% |
80,000
| – | – |
|
16
Abbott
ABT
$231B
| $7.79M | 1.86% |
173,000
-27,000
| -14% | -$1.22M |
|
|
AGN
17
DELISTED
ALLERGAN INC
AGN
| $7.44M | 1.78% |
35,000
| – | – |
|
18
Illumina
ILMN
$15.8B
| $7.38M | 1.76% |
40,000
-3,000
| -7% | -$554K |
|
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| $6.51M | 1.56% |
205,000
+170,000
| +486% | +$5.4M |
|
|
MDVN
20
DELISTED
MEDIVATION, INC.
MDVN
| $6.48M | 1.55% |
65,000
+45,000
| +225% | +$4.48M |
|
21
Cardinal Health
CAH
$35.5B
| $6.46M | 1.54% |
80,000
-25,000
| -24% | -$2.02M |
|
22
Ionis Pharmaceuticals
IONS
$6.79B
| $6.17M | 1.48% |
100,000
-40,000
| -29% | -$2.47M |
|
|
AKRX
23
DELISTED
Akorn, Inc.
AKRX
| $5.79M | 1.38% |
160,000
+100,000
| +167% | +$3.62M |
|
24
Eli Lilly
LLY
$657B
| $5.52M | 1.32% |
80,000
| – | – |
|
|
HSP
25
DELISTED
HOSPIRA INC
HSP
| $5.51M | 1.32% |
+90,000
| New | +$5.51M |
|